Yahoo Québec Recherche sur tout le Web

Résultats de recherche

  1. 30 mai 2024 · A global biopharmaceutical company developing and commercializing innovative protein replacement therapies and precision medicines to serve the unserved rare disease patient. Read more.

  2. Le cours de l'action PHARMING GROUP PHARM sur Boursorama : historique de la cotation sur Euronext Amsterdam, graphique, actualités, consensus des analystes et informations...

  3. 3 juin 2024 · Pharming is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patient.

  4. Find the latest Pharming Group N.V. (PHAR) stock quote, history, news and other vital information to help you with your stock trading and investing.

  5. 3 juin 2024 · Pharming Group N.V. is pleased to announce its recognition as an Industry Innovator by the National Organization for Rare Disorders (NORD®) at the Rare Impact Awards on June 8, 2024. Read more. 2024. Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025.

  6. Find the latest Pharming Group N.V. (PHAR) stock quote, history, news and other vital information to help you with your stock trading and investing.

  7. Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening...

  1. Des personnes ont également recherché